Girish Mahajan (Editor)

Haemaccel

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19

Haemaccel (a registered trademark) is a type of intravenous colloid used in the prevention or treatment of shock associated with reduction in effective circulating blood volume due to hemorrhage, loss of plasma (burns, peritonitis, pancreatitis, crush injuries), or loss of water and electrolytes from persistent vomiting and diarrhea. Haemaccel contains degraded gelatin.

Haemaccel (also marketed as Emagel in Italy, "Polygeline" in China and Solucel in Venezuela) was originally brought to market by Hoechst AG and later acquired by Piramal Enterprises.

References

Haemaccel Wikipedia


Similar Topics
The Kiss (1916 film)
Bob Rankin
Maksim Shatskikh
Topics
 
B
i
Link
H2
L